Stage IA NSCLC Patient Outcomes After VATS with Intrapleural Hemocoagulase

442 stage IA non-small cell lung cancer patients undergoing video-assisted thoracoscopic surgery (VATS) were analyzed in a retrospective study by Yingding Ruan, last updated in April 2026. The dataset compares coagulation profiles and early recovery metrics between patients who received intrapleural Hemocoagulase Bothrops atrox (HBA) and those who did not. It includes outcomes such as prothrombin time, fibrinogen levels, postoperative complications, and hospital length of stay.

Use Cases

• Analyzing the association between intrapleural HBA and postoperative coagulation parameters like prothrombin time and fibrinogen.
• Modeling the impact of HBA on early surgical outcomes, such as complication rates and hospital stay duration.
• Conducting propensity score-weighted analyses on retrospective clinical data to assess treatment effects.

Strengths

• Dataset includes results from 442 patient records, providing a substantive cohort for analysis.
• Specific statistical results are reported, including beta coefficients, confidence intervals, and p-values for key outcomes.
• Analysis employed inverse probability of treatment weighting (IPTW) to balance baseline characteristics.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count for the underlying data tables is unknown, which may limit suitability assessment.
• Data is contained in a 25.8 KB DOCX file, suggesting limited scope and likely summary tables rather than raw patient-level data.

Provenance

Source

figshare, author Yingding Ruan.

Collection Method

Retrospective analysis of patient records.

Time Range

Temporal coverage of the patient cohort is not specified.

Freshness

Last updated 2026-04-10 05:29:34

Geography

Spatial coverage is not specified.